GGrantIndex
← Search

A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF ROSIGLITAZONE IN HIV

$92,162M01FY2004RRNIH

Massachusetts General Hospital, Boston MA

Investigators

Linked publications, trials & patents

View original record on NIH RePORTER →